ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • Search
  • My Favorites
    • View and print all favorites
    • Clear all favorites

Abstract Number: 0495

Correlation Between Triglyceride/Glucose Index and Functional Capacity in Rheumatoid Arthritis Patients

Yelitza Cecilia Velarde Mejia1, Manuel Ugarte-Gil2, Risto Perich3, Cesar Pastor4, Graciela Alarcon5 and RV, Gamboa-Cardenas6, 1Hncase, Arequipa, Peru, 2Universidad Cientifica del Sur, Lima, Lima, Peru, 3Hospital Almenara, Lima, Peru, 4UNMSM, LIMA, Peru, 5The University of Alabama at Birmingham, Oakland, CA, 6Universidad Científica del Sur, Lima, Lima, Peru

Meeting: ACR Convergence 2024

Keywords: Biomarkers, functional status, Health Assessment Questionnaire (HAQ), rheumatoid arthritis

  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print
Session Information

Date: Saturday, November 16, 2024

Title: RA – Diagnosis, Manifestations, & Outcomes Poster I

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: The triglyceride/glucose index (TGI) is a metabolic marker associated with insulin resistance and cardiovascular risk. In patients with Rheumatoid Arthritis (RA), chronic inflammation and prolonged use of glucocorticoids can contribute to metabolic disturbances, including dyslipidemia and dysglycemia. Therefore, the TGI could provide an integrated view of the metabolic status of patients with RA and potentially correlate with functional capacity. Our aim was to evaluate the association between the TGI and functional capacity, as assessed by the Health Assessment Questionnaire (HAQ), in patients with RA.

Methods: This was a cross-sectional analysis of an established RA cohort constituted by patients referred to a Peruvian tertiary care center (the Almenara RA cohort). Patients are being followed every six months with a standard protocol that includes an interview, medical records review, physical examination (including 28 joint counts), and laboratory tests that included fasting glucose and triglycerides. For the present study, we included patients who had a visit between March 2014 and December 2017

For categorical variables, frequencies and percentages were obtained whereas for continuous variables medians and interquartile ranges (IQR) were. A normality test of Kolmogorov-Smirnov was performed. To evaluate the association between TGI with the HAQ [the modified HAQ (mHAQ), the functional HAQ (fnHAQ) and the psychological HAQ (pHAQ)], univariable linear regression models were used. Subsequently, a multivariable linear regression model, adjusted for gender, age, socioeconomic status, tobacco use, disease duration, ACPA (Anti–citrullinated protein antibodies) levels, disease activity (Disease Activity Score-28 with C reactive protein [DAS-28 CRP]), treatment (average dose of glucocorticoids over the last 3 months, cs- DMARDs and b-DMARDs use) and the Charlson comorbidity index.

Results: Two hundred and forty-seven patients were included. The average (SD) age was 63.0 (12.8) years, disease duration was 8.45(1.26) years; nearly all the patients were Mestizo (99.6%) and 229 (92.7%) were women. In the univariable analysis, a higher TGI was associated with higher pHAQ with B=0.73 (p˂0.01) no significant correlation was found with either the mHAQ or the fnHAQ. In the corresponding multivariable analysis, this correlation remained significant with B=0.80 (p˂0.01). The univariable and multivariable analyses are shown in Table 1.

Conclusion: The study demonstrated a significant association between TGI and pHAQ in patients with RA. This finding highlights the potential role of metabolic dysregulation in contributing to psychological distress in RA patients. Further research is warranted to explore the mechanisms underlying the observed associations and to evaluate whether interventions targeting metabolic factors in RA patients could improve psychological outcomes.

Supporting image 1


Disclosures: Y. Velarde Mejia: None; M. Ugarte-Gil: AstraZeneca, 1, 6, Ferrer, 1, GlaxoSmithKlein(GSK), 6, Janssen, 5, Tecnofarma, 2, 6, 12, Travel Support; R. Perich: None; C. Pastor: None; G. Alarcon: None; R. Gamboa-Cardenas: None.

To cite this abstract in AMA style:

Velarde Mejia Y, Ugarte-Gil M, Perich R, Pastor C, Alarcon G, Gamboa-Cardenas R. Correlation Between Triglyceride/Glucose Index and Functional Capacity in Rheumatoid Arthritis Patients [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/correlation-between-triglyceride-glucose-index-and-functional-capacity-in-rheumatoid-arthritis-patients/. Accessed .
  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/correlation-between-triglyceride-glucose-index-and-functional-capacity-in-rheumatoid-arthritis-patients/

Advanced Search

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology